Navigation Links
Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
Date:5/12/2008

tories and Its Products

Forest Laboratories is a U.S.-based pharmaceutical company dedicated to identifying, developing, and delivering products that make a positive difference in people's lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl-D-aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Campral(R)** (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation, and Bystolic(R) (nebivolol), a beta-adrenergic receptor blocking agent indicated for the treatment of hypertension.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., one of Japan's leading pharmaceutical companies and a global leader in pharmaceutical innovation whose roots date back to 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world. The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders. For more information, visit http://www.dsus.com.

* AZOR is a trademark of Daiichi Sankyo, Inc.

**Campral is a registered trademark of Merck Sante s.a.s., a subsidiary of

Merck KGaA, Darmstadt, Germany.

Except fo
'/>"/>

SOURCE Forest Laboratories, Inc.; Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
2. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
3. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
4. Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
5. BioSpace Launches 3rd Edition of BioForest(TM) Bioscience Marketing Campaign
6. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
7. Nanotube forests grown on silicon chips for future computers, electronics
8. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
9. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
10. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
11. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... In preparation for VARTECH 2014, 2FA, Inc., ... focused on authentication and SSO announced today that their ... generate a OTP through the presentation of an RFID ... RFID authentication, 2FA,s solutions have leveraged the existence of ... RFID authentication is broadly deployed in healthcare and other ...
(Date:9/15/2014)... 15, 2014   Global Science & Technology, ... products and services for satellite and weather systems, ... Integrated Services (OASIS) from the General Services Administration ... to provide the government best-value solutions for complex ... category in Pool 4. The OASIS SB award ...
(Date:9/15/2014)... downhill fast when a patient has sepsis, a life-threatening ... patient,s blood -- often too fast for antibiotics to ... and developed by a team at Harvard,s Wyss Institute ... doctors treat sepsis. , "Even with the best ... units at least 30 percent of the time," said ...
(Date:9/15/2014)... , Sept. 15, 2014  iVinci Health LLC, the ... Patient Revenue Management system, branded as VisitPay®, has successfully ... announced the launch of a new extension to VisitPay® ... an easy and convenient way for patients to manage ... owed by them and their families. The ...
Breaking Biology Technology:2FA, Inc. Announces RFID-based One-Time Password (OTP) Authentication 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3
... TAMPA, Fla., May 1 MiMedx Group, Inc. ... Wallace, former,President of UPS International, has been appointed ... Commenting on the appointment, Thomas D,Alonzo, Chief ... of Ron,s stature,independence and knowledge to our Board. ...
... May 1 Sidec announces the first,Protein ... PEGS. This Award,is set up to enable ... not yet collaborated with Sidec on a ... groundbreaking technology successfully used in,cancer drug research., ...
... Doctors Changing the Face of ... ... ENTERPRISE (BE),unveils its 2008 report on the best and brightest in medicine. ... lives through the revolutionary treatment of,diseases, from cancer and diabetes to heart ...
Cached Biology Technology:MiMedx Group, Inc. Adds Ronald G. Wallace to Board of Directors 2Sidec Announces the First Protein Tomography(TM) Award at Sidec's Executive Forum at PEGS 2Black Enterprise Unveils America's Leading Doctors 2Black Enterprise Unveils America's Leading Doctors 3
(Date:9/16/2014)... 2014 As open enrollment season approaches, U.S. employees ... their 2015 benefits. According to Aon Hewitt , ... Aon plc (NYSE: AON ), ... role in managing their health care decisions. This increased ... to understand how they can make the most of ...
(Date:9/15/2014)... (September 15, 2014) The so-called central dogma ... proteinhas long provided a simplified explanation for how ... organisms. , In reality, of course, the ... first articulated nearly 60 years ago by Nobel ... structure. For one, there are multiple types of ...
(Date:9/15/2014)... epilepsy drug to a morphine regimen can result in ... combination can reduce the dosage of the opioid needed ... researchers at Indiana University. , The result could bring ... difficult-to-treat condition often felt in the arms and legs ... a huge unmet need for better treatments for neuropathic ...
Breaking Biology News(10 mins):Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 2Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 3Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 4Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 5Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 6Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 7Scientists discover RNA modifications in some unexpected places 2IU study: Combining epilepsy drug, morphine can result in less pain, lower opioid doses 2
... A new research report published online in The FASEB Journal ... sugar and high fat diets have babies who are likely ... which used rats, this happens because the high fat and ... reward pathway, altering food preferences. Not only does this offer ...
... Minnesota researchers are a key step closer to making renewable ... by a $2.2 million United States Department of Energy grant. ... January, made the critical step by figuring out how to ... bacteria into ketones, which can be cracked to make hydrocarbon ...
... has been used to treat heroin addicts for nearly ... possible harmful effects from prolonged use. New research from ... affects the brain and impairs the attention of experimental ... and morphine are known to weaken intellectual functions such ...
Cached Biology News:'Junk food' moms have 'junk food' babies 2U of M researchers close in on technology for making renewable petroleum 2Long-term methadone treatment can affect the brain 2
... Hollandes is a fixative useful for routine ... It is stable and will decalcify small ... Hollande's can be stained successfully with most ... solution stabilizes red blood cell membranes and ...
... The gold standard for automated ... of bioanalytical applications • Based on ... • Automated accessories designed for bioresearch ... light • Versatility, reliability and ease-of-use ...
... In Vitro Osteogenesis Assay Kit contains all ... a mature osteoblastic lineage, as determined by ... provides all the necessary reagents and a ... plate reader. This product is useful for ...
... Acuity is the complete enterprise microarray informatics platform ... analysis. Buy Acuity once and use it forever ... Tools for Quality Acuity has all the ... from your data, from quality control statistics and ...
Biology Products: